Adelakun NS - Search Results

1

Agemone mexicana flavanones; apposite inverse agonists of the β2-adrenergic receptor in asthma treatment.

Eniafe GO, Metibemu DS, Omotuyi OI, Ogunleye AJ, Inyang OK, Adelakun NS, Adeniran YO, Adewumi B, Enejoh OA, Osunmuyiwa JO, Shodehinde SA, Oyeneyin OE. Eniafe GO, et al. Among authors: adelakun ns. Bioinformation. 2018 Feb 28;14(2):60-67. doi: 10.6026/97320630014060. eCollection 2018. Bioinformation. 2018. PMID: 29618901 Free PMC article.

2

Molecular docking analysis of phyto-constituents from Cannabis sativa with pfDHFR.

David TI, Adelakun NS, Omotuyi OI, Metibemu DS, Ekun OE, Eniafe GO, Inyang OK, Adewumi B, Enejoh OA, Owolabi RT, Oribamise EI. David TI, et al. Among authors: adelakun ns. Bioinformation. 2018 Dec 27;14(9):574-579. doi: 10.6026/97320630014574. eCollection 2018. Bioinformation. 2018. PMID: 31223216 Free PMC article.

3

Flavones scaffold of Chromolaena odorata as a potential xanthine oxidase inhibitor: Induced Fit Docking and ADME studies.

Kikiowo B, Ogunleye AJ, Inyang OK, Adelakun NS, Omotuyi OI, Metibemu DS, David TI, Oludoyi OO, Ijatuyi TT. Kikiowo B, et al. Among authors: adelakun ns. Bioimpacts. 2020;10(4):227-234. doi: 10.34172/bi.2020.29. Epub 2019 Nov 2. Bioimpacts. 2020. PMID: 32983938 Free PMC article.

4

Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer.

Kikiowo B, Ogunleye AJ, Iwaloye O, Ijatuyi TT, Adelakun NS, Alashe WO. Kikiowo B, et al. Among authors: adelakun ns. Recent Pat Anticancer Drug Discov. 2021;16(2):273-284. doi: 10.2174/1574892816666210201115359. Recent Pat Anticancer Drug Discov. 2021. PMID: 33563181

5

Chromolaena odorata flavonoids attenuate experimental nephropathy: Involvement of pro-inflammatory genes downregulation.

Omotuyi OI, Nash O, Enejoh OA, Oribamise EI, Adelakun NS. Omotuyi OI, et al. Among authors: adelakun ns. Toxicol Rep. 2020 Oct 8;7:1421-1427. doi: 10.1016/j.toxrep.2020.10.006. eCollection 2020. Toxicol Rep. 2020. PMID: 33102146 Free PMC article.

6

Discovery of new promising USP14 inhibitors: computational evaluation of the thumb-palm pocket.

Adelakun N, Obaseki I, Adeniyi A, Fapohunda O, Obaseki E, Omotuyi O. Adelakun N, et al. J Biomol Struct Dyn. 2022 Apr;40(7):3060-3070. doi: 10.1080/07391102.2020.1844803. Epub 2020 Nov 10. J Biomol Struct Dyn. 2022. PMID: 33170088

7

T-705-modified ssRNA in complex with Lassa virus nucleoprotein exhibits nucleotide splaying and increased water influx into the RNA-binding pocket.

Omotuyi OI, Nash O, Safronetz D, Ojo AA, Ogunwa TH, Adelakun NS. Omotuyi OI, et al. Among authors: adelakun ns. Chem Biol Drug Des. 2019 Apr;93(4):544-555. doi: 10.1111/cbdd.13451. Epub 2019 Jan 29. Chem Biol Drug Des. 2019. PMID: 30536557

8

Polypharmacology of some medicinal plant metabolites against SARS-CoV-2 and host targets: Molecular dynamics evaluation of NSP9 RNA binding protein.

Bandyopadhyay S, Abiodun OA, Ogboo BC, Kola-Mustapha AT, Attah EI, Edemhanria L, Kumari A, Jaganathan R, Adelakun NS. Bandyopadhyay S, et al. Among authors: adelakun ns. J Biomol Struct Dyn. 2022;40(22):11467-11483. doi: 10.1080/07391102.2021.1959401. Epub 2021 Aug 9. J Biomol Struct Dyn. 2022. PMID: 34370622

9

Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: in vitro validation of furin inhibition.

Omotuyi IO, Nash O, Ajiboye BO, Olumekun VO, Oyinloye BE, Osuntokun OT, Olonisakin A, Ajayi AO, Olusanya O, Akomolafe FS, Adelakun N. Omotuyi IO, et al. Phytother Res. 2021 Feb;35(2):908-919. doi: 10.1002/ptr.6843. Epub 2020 Sep 22. Phytother Res. 2021. PMID: 32964551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters